Atrimustine

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAtrimustine
Drug Alias NameBusramustineBestrabucilKreganKM-2210
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA inhibitorsImmunosuppressants
TargetsDNA
Therapy Area/IndicationsGraft vs Host DiseaseBreast NeoplasmsLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesKureha Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKureha Corporation
Active IndicationsN/A
Inactive IndicationsGraft vs Host DiseaseBreast NeoplasmsLymphoma, Non-Hodgkin

Other Information

ATC CodeN/A
Related LinksKEGG